Skip to content

Smartphone application-based behavioural intervention for cardiac rehabilitation and the effect on hospital readmissions: The ToDo-Cardiac Rehabilitation (ToDo-CR) randomised control trial

Smartphone application-based behavioural intervention for cardiac rehabilitation and the effect on hospital readmissions: The ToDo-Cardiac Rehabilitation (ToDo-CR) randomised control trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001223123
Acronym
ToDo-CR
Enrollment
32
Registered
2019-09-04
Start date
2020-01-20
Completion date
2021-06-30
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Cardiac rehabilitation (CR) is a secondary prevention program for cardiovascular disease with physical activity (PA) being a core component. Despite this, studies have found that PA levels are low and sedentary behaviour (SB) is high in CR patients. The aim of this randomised control trial (RCT) is: 1) to test the efficacy of a behavioural smartphone application (Vire DoACTIVE) and a 6-month online behaviour change program (ToDo-CR) in decreasing SB and increasing PA levels in CR participants (compared to routine CR alone); 2) to explore if this behavioural change intervention is effective at reducing the risk of repeat cardiac events, all cause hospital admissions and emergency department visits over 12-months post commencing CR. We propose to conduct a multi-centre RCT over 12-months with 144 participants from the Canberra Hospital, Calvary Public Hospital Bruce and National Capital Private Hospital CR programs. It is hypothesised that the intervention will increase PA levels, decrease SB and reduce repeat cardiac events, readmissions to hospital and emergency department visits.

Interventions

Study design- The multi-centre, single jurisdiction, RCT will be conducted over 24-months in Canberra Cardiac Rehabilitation (CR) programs using staggered recruitment (the study duration for each individual participant is 12-months). Participants will be assessed on admission to traditional phase II hospital-based CR programs at The Canberra Hospital, Calvary Public Hospital Bruce and National Capital Private Hospital. After being assessed by CR staff, they will be randomly assigned to either ro

Study design- The multi-centre, single jurisdiction, RCT will be conducted over 24-months in Canberra Cardiac Rehabilitation (CR) programs using staggered recruitment (the study duration for each individual participant is 12-months). Participants will be assessed on admission to traditional phase II hospital-based CR programs at The Canberra Hospital, Calvary Public Hospital Bruce and National Capital Private Hospital. After being assessed by CR staff, they will be randomly assigned to either routine CR alone (control group) or the intervention: CR complemented with the ToDo-CR program. Assessor blinding will be used throughout the study. A follow-up assessment at the University of Canberra will be completed at 6-months and 12-months post admission to the CR program. At 12-months, participants will complete a questionnaire regarding information about additional cardiac events, all cause hospital readmissions and visits to the emergency department since commencing CR. If able, this will be verified by hospital patient admission records accessed by CR staff to provide information regarding cardiac and/or all cause readmissions to hospital and visits to the emergency department. Intervention- Arm 1 of RCT Phase II hospital-based CR complimented with the the ToDo-CR program (intervention group): Following entry into the CR program and baseline assessment, those randomised to the ToDo-CR program will be given a Fitbit, shown how to install the Fitbit and Vire DoACTIVE (Vire in short) application (app/s) on their smartphone and how to use them by the CR staff. These participants will be required to wear the Fitbit for the 12-month study period and will be able to keep the Fitbit on completion of the study. CR staff will provide the CR program as usual with no extra encouragement or support for these participants to decrease sedentary behaviour or increase physical activity during their 6-week CR program. Vire and ToDo-CR are considered to be one intervention. The Vire app is used to deliver the ToDo-CR program. ToDo-CR is an online behaviour change service delivered through a smartphone app created by Onmi in collaboration with Do Something Limited. The ToDo-CR program used in this study will focus on the behavioural pillars ‘activity’ and ‘exercise’. The ToDo-CR program is designed to help people learn new behaviours so they have more choice over how they react to different situations. The system suggests micro behavioural alternatives (Do's) that gradually change people’s habits. This is based on evidence that these small behavioural changes effect health outcomes. At the intake of the program a set of diagnostic questions will be answered by the patient on the Vire app. The unique program of behavioural prompts (Do’s) will be based on the person’s answers to the diagnostic questions. Each personalised program consists of different types of Do’s delivered through the smartphone app: Core Do’s and Data Driven Do’s. Core Do’s address the individual’s psychology and the factors that often prevent healthy changes. These Do’s are selected based on intake questionnaires at the beginning of the program. For example, if a person responds that they spend most evenings watching TV or in front of a screen a lot of the time, the following Core Do may be sent: "SCREEN-FREE EVENING. Supercharge your evening - hit the Off button on TV/screens. Do something different e.g. play games, music, dance or phone a friend". Data Driven Do’s, address their everyday context that traps them in habitual behaviour, fusing data from the Fitbit (acceleration) and Vire (GPS) to create a comprehensive digital profile of the individual, with near real-time analysis algorithms. For example, if the variety in acceleration and GPS data is low, the following Data Driven Do may be sent: "GO SOMEWHERE NEW. It's time for a change. Explore a new area on foot, or walk down a street you have never been on". For a duration of one week, baseline measurements will be collected. This is used to calibrate the program triggers for sending Data Driven Do’s. The calibration uses absolute and relative behaviour (i.e. actual amount of steps and relative increases or decreases). The system computes variable scores based on the person's behaviour. When the system identifies a need for improvement, an appropriate Do is sent. By combining technology, evidence-based guidelines and psychology, the program aims to increase the patient’s self-efficacy, with the goal to decrease their sedentary behaviour and increase their moderate-vigorous physical activity. Vire also presents a 14-day overview. Here the patient can observe trends in their acceleration and GPS data showing their levels of activity, variety and social opportunity. This can help them to understand why a certain Do was dispatched in relation to why they may have been prompted to move more or try go somewhere different to usual.  The ToDo-CR program will be delivered for 6-months, however, the Vire app (an interface to show daily activity, social opportunity and variety) will be available to the participants for the entire 12-months. Participants are required to try and engage with the Vire app and open their Fitbit app daily in order to generate data and get the most out of the ToDo-CR program over the 6-months of the intervention. A research team member (not involved in the data collection) will be able to access an online dashboard which indicates how frequently the users are interacting with the Vire app to monitor adherence to the intervention. If it is shown that a participant has not accessed the app in 3 days, they will be contacted by this member of the research team to obtain why this is and if their is a technical problem hindering the participant from engaging. This contact will cease at completion of the 6-month ToDo-CR program. Participants will also be sent a Do if they have not accessed their app or the Vire app has not been able to sync with the Fitbit app for 3 days. The purpose of the follow up measure at 12-months post commencing CR, is to then assess whether the ToDo-CR program helps facilitate sustained behaviour change. Control- Arm 2 of RCT Phase II hospital-based CR alone (control group). Materials- smartphone, smartphone application (Vire DoACTIVE) which delivers the 6-month behaviour change program ToDo-CR, FitBits, ActiGraph triaxial commercial accelerometers, demographic questionnaire, Quality of Life questionnaire, anxiety and depression questionnaire, stage of behaviour change questionnaire, smartphone application usability questionnaire.

Sponsors

University of Canberra
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants will be eligible to take part in the study if they are aged 18+, are currently enrolled in the phase II CR programs at TCH, Calvary and NCPH and have a smartphone compatible with the apps. Participants will be included if they have stable CHD and are receiving optimal medical treatment +/- revascularisation (i.e. coronary artery bypass graft surgery (CABG), percutaneous coronary intervention (PCI)), or have had a myocardial infarction (MI). Eligible participants must have adequate language (English speaking) and vision to use/operate their smartphone. Participants must have adequate cognitive skills to agree to take part in the RCT, understanding what will be required of them. The CR staff will determine whether a participant has adequate cognitive skills to be involved in the study, assessing their level of understanding via methods such as getting the participants to repeat back what they are agreeing to and their understanding of the research project. No formal testing of cognition will take place.

Exclusion criteria

Participants will be excluded if they have New York Heart Association class II-IV symptoms of heart failure (or documented signs and symptoms of chronic heart failure, with ejection fraction < 45%), uncontrolled arrhythmias, severe chronic obstructive pulmonary disease, uncontrolled hypertension, symptomatic peripheral artery disease, unstable angina, uncontrolled diabetes, are unable to perform a submaximal walking test, or are unable to wear an accelerometer due to disability (e.g. if they are confined to a wheelchair). Participants will also be excluded if they have a pre-paid phone plan (limited data availability) or if the smartphone’s operating system is not compatible with all apps.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 17, 2026